GT
ELV icon

Greenleaf Trust’s Elevance Health ELV Stock Holding History

Greenleaf Trust’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
4,989
+157
+3% +$58.2K 0.02% 220
2026
Q1 		$1.41M Sell
4,832
-175
-3% -$57.5K 0.01% 268
2025
Q4 		$1.76M Sell
5,007
-244
-5% -$82.5K 0.02% 230
2025
Q3 		$1.7M Sell
5,251
-709
-12% -$221K 0.02% 229
2025
Q2 		$2.32M Sell
5,960
-906
-13% -$364K 0.02% 175
2025
Q1 		$2.99M Buy
6,866
+975
+17% +$391K 0.03% 146
2024
Q4 		$2.17M Sell
5,891
-1,162
-16% -$486K 0.02% 186
2024
Q3 		$3.67M Sell
7,053
-88
-1% -$47K 0.03% 123
2024
Q2 		$3.87M Buy
7,141
+158
+2% +$83.5K 0.04% 115
2024
Q1 		$3.62M Buy
6,983
+23
+0.3% +$11.4K 0.03% 117
2023
Q4 		$3.28M Sell
6,960
-343
-5% -$159K 0.04% 120
2023
Q3 		$3.18M Sell
7,303
-74
-1% -$33.6K 0.04% 113
2023
Q2 		$3.28M Buy
7,377
+314
+4% +$145K 0.03% 117
2023
Q1 		$3.25M Sell
7,063
-210
-3% -$99.9K 0.04% 119
2022
Q4 		$3.73M Buy
7,273
+393
+6% +$200K 0.05% 103
2022
Q3 		$3.13M Sell
6,880
-114
-2% -$54.5K 0.05% 110
2022
Q2 		$3.38M Sell
6,994
-641
-8% -$317K 0.05% 95
2022
Q1 		$3.75M Sell
7,635
-155
-2% -$70.9K 0.04% 84
2021
Q4 		$3.61M Buy
7,790
+2,603
+50% +$1.1M 0.04% 88
2021
Q3 		$1.93M Buy
5,187
+47
+0.9% +$17.9K 0.02% 125
2021
Q2 		$1.96M Sell
5,140
-4
-0.1% -$1.53K 0.02% 128
2021
Q1 		$1.85M Sell
5,144
-320
-6% -$103K 0.02% 123
2020
Q4 		$1.75M Buy
5,464
+291
+6% +$89.3K 0.02% 121
2020
Q3 		$1.39M Sell
5,173
-36
-0.7% -$9.69K 0.02% 128
2020
Q2 		$1.37M Sell
5,209
-528
-9% -$141K 0.02% 125
2020
Q1 		$1.3M Buy
5,737
+852
+17% +$232K 0.03% 107
2019
Q4 		$1.48M Sell
4,885
-59
-1% -$16.2K 0.02% 128
2019
Q3 		$1.19M Sell
4,944
-1,100
-18% -$301K 0.02% 140
2019
Q2 		$1.71M Buy
6,044
+79
+1% +$21.6K 0.03% 108
2019
Q1 		$1.71M Buy
5,965
+1,489
+33% +$431K 0.03% 104
2018
Q4 		$1.18M Buy
4,476
+275
+7% +$75.6K 0.02% 135
2018
Q3 		$1.15M Buy
4,201
+138
+3% +$35.8K 0.02% 151
2018
Q2 		$967K Buy
4,063
+537
+15% +$124K 0.02% 166
2018
Q1 		$775K Buy
3,526
+3,481
+7,736% +$818K 0.02% 181
2017
Q4 		$10K Sell
45
-3,156
-99% -$672K ﹤0.01% 657
2017
Q3 		$608K Buy
3,201
+565
+21% +$108K 0.01% 195
2017
Q2 		$496K Buy
2,636
+1,308
+98% +$235K 0.01% 199
2017
Q1 		$220K Buy
+1,328
New +$211K 0.01% 274

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Greenleaf Trust's ELV Position: Q2 2026 in Review

Greenleaf Trust increased its Elevance Health (ELV) stake by 3.2% in Q2 2026, buying an estimated $58.2K and bringing the position to 4,989 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #220.

Greenleaf Trust first reported a position in ELV in Q1 2017 and has held it in 38 quarters since. The position peaked at $3.87M in Q2 2024. 594 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Greenleaf Trust held 4,989 shares of Elevance Health worth $1.93M as of Q2 2026.
  • Greenleaf Trust bought 157 Elevance Health shares in Q2 2026, an estimated $58.2K.
  • Elevance Health made up 0.02% of Greenleaf Trust's portfolio in Q2 2026, its #220 holding.
  • Greenleaf Trust first reported a position in Elevance Health in Q1 2017 and has held it in 38 quarters since.
  • Greenleaf Trust's Elevance Health position peaked at $3.87M in Q2 2024.
  • 594 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.